|Articles|November 1, 1998

November 1998
Volume 4
Issue 11

The Ethical Dilemma of Population-Based Medical Decision Making

Author(s)Robert S. Kirsner, MD, Daniel G. Federman, MD

Download PDF: The Ethical Dilemma of Population-Based Medical Decision Making

Articles in this issue

over 27 years ago

Article

Discontinuity of Care: Urgent Care Utilization Within a Health Maintenance Organization

over 27 years ago

Article

Explaining Price Variations for the Inpatient Treatment of Congestive Heart Failure

over 27 years ago

Article

Consequences of Intermittent Treatment for Hypertension: The Case for Medication Compliance and Persistence

over 27 years ago

Article

Efficacy, Safety, and Impact on Quality of Life of Salmeterol in Patients With Moderate Persistent Asthma

over 27 years ago

Article

Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer

over 27 years ago

Article

Ventricular Arrhythmias and the Use of Antiarrhythmic Drugs After Cardiovascular Surgery

over 27 years ago

Article

Methods of Evaluation in Outcomes Research

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

The Ethical Dilemma of Population-Based Medical Decision Making

Articles in this issue

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis

Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes

The Emerging Role of Factor XIa Inhibition in Stroke Prevention